INSIGHTS
Company Attendee List
This curated list showcases the key industry leaders who will be present, offering a unique opportunity to engage with decision-makers, explore new collaborations, and stay ahead in the rapidly evolving pharma and biotech sectors. Download the list now to prepare for valuable networking and insights at this premier event.
Explore an array of supplementary content that will prepare you for the Global Pharma and Biotech Summit, this November.
Event Brochure
The Global Pharma and Biotech Summit brings professionals in the world of life sciences together to network and share insights into exciting trends shaping the future of the sector. With a speaker line-up that includes big pharma CEOs, biotech investors, healthcare providers and patient advocates, you will get a wide variety of perspectives on pertinent issues facing businesses as they endeavour to innovate and bring cutting-edge treatments to market.
Download the summit brochure to find out more.
Reports

Obesity Drugs: Market Dynamics and Growth Potential
The era-defining success of GLP-1 agonists as treatments for obesity and the explosion in demand for them is fueling innovation and investment in the field. Get a taste of what's being covered at this year's Global Pharma and Biotech Summit by downloading our industry report on 'Obesity Drugs: Market Dynamics and Growth Potential'.
Innovation in Healthcare
FT Live's latest industry report delves into European healthcare and life sciences innovation through selected articles on regional biotech valuations, EU health policy shifts and data-sharing in rare disease research.
Investing in Biotech
Biotech companies are at the forefront of developing tranformative solutions to some of the world's most pressing challenges. But what does the investment landscape look like? The report should highlight the level of insights and discussions you can expect from the Global Pharma and Biotech Summit this November.
2023 Content
Explore the highlights and key takeaways from every session of the Global Pharma and Biotech Summit 2023.
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice